Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)-Reference-Cited by-同舟云学术

Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)

Published:2017 Issue:6 Volume:40 Page:739-750
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Endo Yasuo¹,Kumamoto Hiroyuki²,Nakamura Masanori³,Sugawara Shunji⁴,Takano-Yamamoto Teruko⁵,Sasaki Keiichi⁶,Takahashi Tetsu¹

Affiliation:

1. Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University

2. Division of Oral Pathology, Graduate School of Dentistry, Tohoku University

3. Department of Oral Anatomy and Developmental Biology, School of Dentistry, Showa University

4. Division of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku University

5. Division of Orthodontics and Dentofacial Orthopedics, Graduate School of Dentistry, Tohoku University

6. Division of Advanced Prosthetic Dentistry, Graduate School of Dentistry, Tohoku University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/6/40_b16-01020/_pdf

Reference103 articles.

1. 1) Fleisch H. Diphosphonates: history and mechanisms of actions. Metab. Bone Dis. Relat. Res., 3, 279–287 (1981).

2. 2) Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J. Oral Maxillofac. Surg., 61, 1115–1117 (2003).

3. 3) Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J. Clin. Oncol., 21, 4253–4254 (2003).

4. 4) Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int. J. Oral Maxillofac. Surg., 44, 568–585 (2015).

5. 5) Geddes AD, D’Souza SM, Ebetino FH, Kenneth JI. Bisphosphonates: structure–activity relationships and therapeutic implications. Bone and Mineral Research (Heershe NM, Kanis JK ed.) Vol. 8, Elsevier Science BV, Amsterdam, Holland, pp. 265–306 (1994).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alendronate reduces periosteal microperfusion in vivo;Heliyon;2023-09

2. Syntheses of 25-Adamantyl-25-alkyl-2-methylidene-1α,25-dihydroxyvitamin D3 Derivatives with Structure–Function Studies of Antagonistic and Agonistic Active Vitamin D Analogs;Biomolecules;2023-07-06

3. Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures;Journal of Clinical Medicine;2023-06-02

4. A multifunctional composite hydrogel promotes treatment of bisphosphonate-related osteonecrosis of the jaws;Applied Materials Today;2023-06

5. Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study;Bone Reports;2023-06